Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes
Background: Metastatic prostate cancer (CaP) treatments are evolving rapidly but without evidence-based biomarkers to predict responses, and to maximize remissions and survival. Objective: To determine the activity of androgen receptor (AR), the target for default first-line systemic treatment, in l...
Main Authors: | Salma Ben-Salem, Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irene Wang, Varadha Balaji Venkadakrishnan, Dhirodatta Senapati, Sangeeta Kumari, Deli Liu, Andrea Sboner, Christopher E. Barbieri, Felix Feng, Jean-Noel Billaud, Elai Davicioni, Song Liu, Hannelore V. Heemers |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | European Urology Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266616832035833X |
Similar Items
-
Androgen receptor co-regulation in prostate cancer
by: Dhirodatta Senapati, et al.
Published: (2020-07-01) -
Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer
by: Gaurav Chauhan, et al.
Published: (2021-08-01) -
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
by: Song Liu, et al.
Published: (2017-08-01) -
Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
by: Song Liu, et al.
Published: (2017-11-01) -
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
by: Yunjing Zeng, et al.
Published: (2018-06-01)